HIV Caregivers Need Support, Too
Being a caregiver for someone with HIV has its own unique rewards and challenges. As social worker Sarah Biel-Cunningham writes, having a strong support network can be as important for caregivers as it is for people living with HIV.
Never Forget: What We Need Most Is a Cure
With all the new HIV medications and diagnostic tools now in existence, have we, our community leaders, activists, doctors, researchers and bureaucrats forgotten that what people with HIV really need is a cure? Click here to read this inspiring article.
Legal/Financial Issues for Those Returning to Work
Tens of thousands of people with HIV who are on disability want to return to work at least part time, but are afraid they'll lose their hard-won medical benefits or disability income, only to find themselves unable to work again in the future. Read this interview with Eric Ciasullo, who talks about the medical, financial/legal and vocational issues involved in going back to work.
New HAART Guidelines Released by U.S. Health Dept.
The U.S. Department of Health and Human Services has released newly updated HIV antiretroviral guidelines for adults and adolescents. Among the changes are an explanation of the difference between "preferred" and "alternative" treatment regimens, information about the roles that atazanavir (Reyataz) and FTC (emtricitabine, Emtriva) can play in treatment, and new warnings about several drug combinations that should generally be avoided. The updated guidelines include a "What's New" page that briefly summarizes these changes.
When Is T-20 at Its Best?
Who is most likely to benefit from T-20 (enfuvirtide, Fuzeon)? Click here for Cal Cohen, M.D.'s review of what clinical studies on T-20 have shown about the conditions under which it is most effective.
Quick Review of Some of 2003's New Meds
This year, new HIV drug approvals seem to be coming so fast and furious that it's hard to keep track of which new medication does what. This brief article from Project Inform highlights what you need to know about three of the year's newest meds: T-20 (enfuvirtide, Fuzeon), atazanavir (Reyataz) and FTC (emtricitabine, Emtriva).
Thousands With AIDS in Latin America Don't Get Treatment
Hundreds of thousands of people with HIV/AIDS in Latin America face opportunistic infections and death if they don't receive access to treatment. The Agua Buena Human Rights Foundation, which advocates for people with HIV throughout Latin America, has compiled this chart outlining just how large the treatment gap is in some countries.
Five Steps to Changing Your Life After HIV
Change: It's easy to talk about, but much harder to do, even when you're faced with something as life-altering as HIV infection. Peer counselor Mary Lynn Hemphill talks about a five-step process toward change that many people with HIV can follow to help make their lives happier and healthier.
33 Percent of Medical Injections Are Unsafe in Developing World
People throughout the developing world receive too many injections, and one in three of those injections is given with an unsterile needle, increasing the risk of HIV transmission, according to a recent study.
Want to Support the Fight for Microbicides?
Want to get involved in the worldwide push for microbicide development? Several grassroots groups in the U.S. and Canada are looking for more members and supporters; click here to take a closer look.
Chronic Stress: Silent But Crippling
Chronic stress can sneak up on you and wear you down before you even realize it. Health counselor Gary Rosard reviews some easy, effective ways for you to reduce your stress levels without completely altering your lifestyle.
Buy Yourself a Postcard From the Edge
Visual AIDS will hold its 6th annual Postcards From the Edge benefit on Sunday, Nov. 16 in New York City. Hosted this year by Galerie Lelong, this eagerly awaited event features hundreds of postcard-sized works donated by various talented artists, some of whom are widely renowned.
When Your Perm Comes With HIV Education
In a unique and brilliant attempt to reach women who may need HIV prevention or other health information, Vermont's "Operation Hairspray" enlists hairdressers to spread awareness.
HIV in Men and Women: What's the Difference?
Does HIV progress differently in men and women? Although there seem to be differences, the news is that women live as long and maybe even longer than men with HIV. Read this terrific summary on the research to date, from Project Inform.
Registration Deadline Approaches for Next Retrovirus Conference
November 14 is the deadline for both community scholarship applications and community newsletter press applications for the most important AIDS conference of the year: the 11th Conference on Retroviruses and Opportunistic Infections, which will take place Feb. 8-11, 2004, in San Francisco.
Protests Continue Against Circus for HIV Discrimination
The widely acclaimed acrobatic extravaganza known as Cirque du Soleil has been dogged by protests this year in the U.S. over a reported case of HIV discrimination. Lambda Legal and other groups throughout the country are holding events to draw attention to their cause, which centers around an HIV-positive acrobat who was fired by the circus specifically because of his status.
Support Faith-Based Groups in Moderation, Advocates Urge
AIDS Action looks at faith-based AIDS organizations in the U.S. and, in particular, how President George W. Bush's "Faith-Based and Community Initiative" would impact them. AIDS Action urges the Bush administration to ensure that its support of faith-based organizations includes a wide range of religions, and that those groups use scientifically evaluated methods in their delivery of HIV prevention, care and support.
A Selection of the Top HIV/AIDS Stories From Across the Internet:
HIV Partners "Should Get Drugs"
Researchers in London want to study whether HIV medications can
be used to prevent HIV infections, perhaps by giving one pill to
HIV-negative people before they have sex with their HIV-positive
partners. Some worry, however, that doing so might discourage
From BBC News (November 11, 2003)
What Did We Learn From AIDS?
How the discovery of HIV has led to dramatic evolutions in medical
science, ethics and the neglected field of compassionate care for
From The New York Times (November 11, 2003)
Green Tea Extract May Fight HIV
A chemical found in green tea could form the basis of a new
generation of HIV drugs, researchers say.
From BBC News (November 10, 2003)
Censoring Research on AIDS
One of the researchers who recently found out that her work is
being investigated by the U.S. National Institutes of Health
explains why science must remain separate from religion and politics.
From The San Francisco Chronicle (November 6, 2003)
Limited AIDS Drugs Force Doctors to Play God
The dire HIV treatment situation developing in Thailand and
throughout Asia has forced many doctors to decide which of their
patients should get HIV meds and which must go without.
From Inter Press Service (October 14, 2003)